Here's Why Integra LifeSciences (IART) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research7/9/2026Positive
IART
Integra LifeSciences HoldingsNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$1.35B
P/E Ratio
—
EPS
$-6.42
Beta
1.22
52W High
$18.92
52W Low
$8.70
50-Day MA
$15.62
200-Day MA
$12.94
Dividend Yield
—
Profit Margin
-30.10%
Forward P/E
7.32
PEG Ratio
0.67
About Integra LifeSciences Holdings
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, limb reconstruction, orthopedics, and general surgery. The company is headquartered in Princeton, New Jersey.
Fundamentals
| Revenue (TTM) | $1.64B |
| Gross Profit (TTM) | $932.69M |
| EBITDA | $308.30M |
| Operating Margin | 10.40% |
| Return on Equity | -38.60% |
| Return on Assets | 2.54% |
| Revenue/Share (TTM) | $21.41 |
| Book Value | $13.39 |
| Price-to-Book | 1.34 |
| Price-to-Sales (TTM) | 0.82 |
| EV/Revenue | 1.931 |
| EV/EBITDA | 15.34 |
| Quarterly Earnings Growth (YoY) | 0.40% |
| Quarterly Revenue Growth (YoY) | 2.40% |
| Shares Outstanding | $77.80M |
| Float | $58.69M |
| % Insiders | 14.30% |
| % Institutions | 100.53% |
Historical Volatility
HV 10-Day
38.34%
HV 20-Day
41.74%
HV 30-Day
50.72%
HV 60-Day
69.38%
HV Rank
42.5%
Volatility is currently contracting
Analyst Ratings
Consensus ($17.43 target)
1
Strong Buy1
Buy6
Hold2
Strong SellLatest News
Integra (IART) Is Attractively Priced Despite Fast-paced Momentum
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Integra (IART) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Zacks Investment Research7/9/2026Positive
IART or SONVY: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Instruments sector might want to consider either Integra LifeSciences (IART) or SONOVA HOLDING (SONVY). But which of these two stocks is more attractive to value investors?
Zacks Investment Research7/6/2026Neutral
Integra LifeSciences Appoints Topaz Kirlew Chief Regulatory Officer
Kirlew will lead Integra's global regulatory affairs organization as the company continues to strengthen quality, compliance, and execution. Kirlew will lead Integra's global regulatory affairs organization as the company continues to strengthen quality, compliance, and execution.
GlobeNewsWire7/2/2026Neutral
Bet on These 3 Stocks as Broker Rating Upgrades Signal Upside
MITT, SVM and IART stand out as broker rating upgrades, earnings growth forecasts and screen criteria point to potential upside.
Zacks Investment Research6/23/2026Positive
Integra LifeSciences Announces Key Executive Appointments
PRINCETON, N.J., June 23, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Corporation Holdings (Nasdaq: IART), a global leader in medical technology, today announced several leadership appointments within its commercial organization.
GlobeNewsWire6/23/2026Neutral
Here's Why Integra LifeSciences (IART) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research6/22/2026Positive
Integra (IART) Shows Fast-paced Momentum But Is Still a Bargain Stock
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Integra (IART) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Zacks Investment Research6/22/2026Positive
Integra LifeSciences: New Beginning
Integra LifeSciences specializes in neuro-related surgical devices and regenerative tissue technologies. The tissue reconstruction segment, featuring collagen-based products like Integra Skin and PriMatrix, is positioned as IART's primary future earnings driver. IART suffered significant earnings declines and a 75% share price drop due to FDA-related product recalls and operational lapses at its Boston facility.
Seeking Alpha6/22/2026Negative
IART vs. SONVY: Which Stock Is the Better Value Option?
Investors interested in Medical - Instruments stocks are likely familiar with Integra LifeSciences (IART) and SONOVA HOLDING (SONVY). But which of these two stocks is more attractive to value investors?
Zacks Investment Research6/19/2026Positive
More HEALTHCARE Stocks
Data last updated: 7/9/2026